Avian Influenza Virus (H5N1): a Threat to Human Health

SUMMARY Pandemic influenza virus has its origins in avian influenza viruses. The highly pathogenic avian influenza virus subtype H5N1 is already panzootic in poultry, with attendant economic consequences. It continues to cross species barriers to infect humans and other mammals, often with fatal outcomes. Therefore, H5N1 virus has rightly received attention as a potential pandemic threat. However, it is noted that the pandemics of 1957 and 1968 did not arise from highly pathogenic influenza viruses, and the next pandemic may well arise from a low-pathogenicity virus. The rationale for particular concern about an H5N1 pandemic is not its inevitability but its potential severity. An H5N1 pandemic is an event of low probability but one of high human health impact and poses a predicament for public health. Here, we review the ecology and evolution of highly pathogenic avian influenza H5N1 viruses, assess the pandemic risk, and address aspects of human H5N1 disease in relation to its epidemiology, clinical presentation, pathogenesis, diagnosis, and management.

[1]  C. Fraser,et al.  Reducing the impact of the next influenza pandemic using household-based public health interventions. , 2006, Hong Kong medical journal = Xianggang yi xue za zhi.

[2]  A. Kumar,et al.  Three Indonesian Clusters of H5N1 Virus Infection in 2005 , 2008 .

[3]  Update: WHO-confirmed human cases of avian influenza A (H5N1) infection, November 2003-May 2008. , 2008, Releve epidemiologique hebdomadaire.

[4]  D. Tang,et al.  Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. , 2007, Vaccine.

[5]  S. Lowther,et al.  Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. , 2007, Virology.

[6]  A. Cliff,et al.  Avian Influenza A (H5N1) Age Distribution in Humans , 2007, Emerging infectious diseases.

[7]  Y. Guan,et al.  Risk for Infection with Highly Pathogenic Influenza A Virus (H5N1) in Chickens, Hong Kong, 2002 , 2007, Emerging infectious diseases.

[8]  E. Mundt,et al.  Molecular analysis of highly pathogenic avian influenza virus of subtype H5N1 isolated from wild birds and mammals in northern Germany. , 2007, The Journal of general virology.

[9]  J. Peiris,et al.  Comparative analytical sensitivities of six rapid influenza A antigen detection test kits for detection of influenza A subtypes H1N1, H3N2 and H5N1. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[10]  Larry R. Smith,et al.  Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans , 2007, PLoS medicine.

[11]  S. Revilla-Fernández,et al.  Subclinical Infection with Avian Influenza A H5N1 Virus in Cats , 2007, Emerging infectious diseases.

[12]  Yan Li,et al.  Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus , 2007, Nature.

[13]  Y. Guan,et al.  Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract , 2007, Nature Medicine.

[14]  M. V. Van Kerkhove,et al.  Interaction Between Humans and Poultry, Rural Cambodia , 2007, Emerging infectious diseases.

[15]  D. Snydman Avian Influenza A (H5N1) Infection in Eastern Turkey in 2006 , 2007 .

[16]  J. Sheehan,et al.  Innate immunity and mucus structure and function. , 2008, Novartis Foundation symposium.

[17]  T. Tumpey,et al.  Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice , 2006, Journal of Virology.

[18]  P. Daszak,et al.  Predicting the global spread of H5N1 avian influenza , 2006, Proceedings of the National Academy of Sciences.

[19]  D. Chadwick,et al.  Innate Immunity to Pulmonary Infection , 2006 .

[20]  N. Tien,et al.  Risk Factors for Human Infection with Avian Influenza A H5N1, Vietnam, 2004 , 2006, Emerging infectious diseases.

[21]  A. Oner,et al.  Avian influenza A (H5N1) infection in eastern Turkey in 2006. , 2006, The New England journal of medicine.

[22]  Yi Guan,et al.  Three Indonesian clusters of H5N1 virus infection in 2005. , 2006, The New England journal of medicine.

[23]  N. Cox,et al.  Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. , 2006, Vaccine.

[24]  David J. Stevens,et al.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors , 2006, Nature.

[25]  N. Cox,et al.  Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. , 2006, Vaccine.

[26]  Tsugunori Notomi,et al.  Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection. , 2006, Vaccine.

[27]  Gavin J. D. Smith,et al.  Emergence and predominance of an H5N1 influenza variant in China , 2006, Proceedings of the National Academy of Sciences.

[28]  Raymond Tellier,et al.  Review of Aerosol Transmission of Influenza A Virus , 2006, Emerging infectious diseases.

[29]  Hualan Chen,et al.  Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza Viruses , 2006, Journal of Virology.

[30]  S. Hoffman,et al.  Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment? , 2006, Annals of Internal Medicine.

[31]  R. Webby,et al.  Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice , 2006, Respiratory research.

[32]  Ian A. Wilson,et al.  Glycan microarray technologies: tools to survey host specificity of influenza viruses , 2006, Nature Reviews Microbiology.

[33]  D. Swayne,et al.  Principles for Vaccine Protection in Chickens and Domestic Waterfowl against Avian Influenza , 2006, Annals of the New York Academy of Sciences.

[34]  K. Subbarao,et al.  Emerging Respiratory Viruses: Challenges and Vaccine Strategies , 2006, Clinical Microbiology Reviews.

[35]  Philippe Buchy,et al.  Low Frequency of Poultry-to-Human H5N1 Transmission, Southern Cambodia, 2005 , 2006, Emerging infectious diseases.

[36]  E. Turpin,et al.  Inhibition of Influenza Virus Infection by a Novel Antiviral Peptide That Targets Viral Attachment to Cells , 2006, Journal of Virology.

[37]  Yu Wang,et al.  Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial , 2006, The Lancet.

[38]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[39]  David J. Stevens,et al.  The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design , 2006, Nature.

[40]  B. Murphy,et al.  Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets , 2006, PLoS medicine.

[41]  M. Keeling,et al.  Silent spread of H5N1 in vaccinated poultry , 2006, Nature.

[42]  N. Cox,et al.  Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model , 2006, Proceedings of the National Academy of Sciences.

[43]  M. Kieny,et al.  Development of vaccines against influenza H5. , 2006, The Lancet. Infectious diseases.

[44]  M. Saad,et al.  Qinghai-like H5N1 from Domestic Cats, Northern Iraq , 2006, Emerging infectious diseases.

[45]  P. Horby,et al.  Avian influenza H5N1 in viverrids: implications for wildlife health and conservation , 2006, Proceedings of the Royal Society B: Biological Sciences.

[46]  A. Osterhaus,et al.  Avian Flu: Multiple introductions of H5N1 in Nigeria , 2006, Nature.

[47]  Gavin J. D. Smith,et al.  Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. , 2006, Virology.

[48]  R. Webster,et al.  Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. , 2006, Antiviral research.

[49]  Wei Wang,et al.  Fatal infection with influenza A (H5N1) virus in China. , 2006, The New England journal of medicine.

[50]  Y. Kawaoka,et al.  Properties and Dissemination of H5N1 Viruses Isolated during an Influenza Outbreak in Migratory Waterfowl in Western China , 2006, Journal of Virology.

[51]  Gavin J. D. Smith,et al.  Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. , 2006, The Journal of infectious diseases.

[52]  P. Bhattarakosol,et al.  H5N1 Influenza A Virus and Infected Human Plasma , 2006, Emerging infectious diseases.

[53]  Gabriele Neumann,et al.  Host Range Restriction and Pathogenicity in the Context of Influenza Pandemic , 2006, Emerging infectious diseases.

[54]  M. Zambon,et al.  Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial , 2006, The Lancet.

[55]  A. Gibbs,et al.  Molecular virology: Was the 1918 pandemic caused by a bird flu? Was the 1918 flu avian in origin? (Reply) , 2006, Nature.

[56]  D. Cummings,et al.  Strategies for mitigating an influenza pandemic , 2006, Nature.

[57]  J. Kaiser A One-Size-Fits-All Flu Vaccine? , 2006, Science.

[58]  E. Holmes,et al.  Host Species Barriers to Influenza Virus Infections , 2006, Science.

[59]  Ian A. Wilson,et al.  Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus , 2006, Science.

[60]  Thijs Kuiken,et al.  H5N1 Virus Attachment to Lower Respiratory Tract , 2006, Science.

[61]  T. Kuiken,et al.  Feline friend or potential foe? , 2006, Nature.

[62]  R. Pierce,et al.  Kupffer cell-dependent hepatitis occurs during influenza infection. , 2006, The American journal of pathology.

[63]  J. Peiris,et al.  Functional Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Production by Avian Influenza Virus–Infected Macrophages , 2006, The Journal of infectious diseases.

[64]  A. Amonsin,et al.  Avian Influenza H5N1 in Naturally Infected Domestic Cat , 2006, Emerging infectious diseases.

[65]  R. Webster,et al.  Domestic Ducks and H5N1 Influenza Epidemic, Thailand , 2006, Emerging infectious diseases.

[66]  Hongjie Yu,et al.  Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China. , 2006, The New England journal of medicine.

[67]  Mark Wolff,et al.  Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. , 2006, The New England journal of medicine.

[68]  Yoshihiro Kawaoka,et al.  Avian flu: Influenza virus receptors in the human airway , 2006, Nature.

[69]  R. Webster,et al.  The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04 , 2006, The Journal of experimental medicine.

[70]  C. Naeve,et al.  Large-Scale Sequence Analysis of Avian Influenza Isolates , 2006, Science.

[71]  D. Pérez,et al.  Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. , 2006, Virology.

[72]  Lin Yang,et al.  Influenza-Associated Hospitalization in a Subtropical City , 2006, PLoS medicine.

[73]  J. C. Howton Probenecid with oseltamivir for human influenza A (H5N1) virus infection? , 2006, The New England journal of medicine.

[74]  N. Cox,et al.  Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. , 2006, JAMA.

[75]  Y. Guan,et al.  Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Katz,et al.  Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice , 2006, The Lancet.

[77]  M. Gilbert,et al.  Free-grazing Ducks and Highly Pathogenic Avian Influenza, Thailand , 2006, Emerging infectious diseases.

[78]  M. Kieny,et al.  Development and evaluation of influenza pandemic vaccines , 2006, The Lancet Infectious Diseases.

[79]  Samson S. Y. Wong,et al.  Avian Influenza Virus Infections in Humans , 2006, Chest.

[80]  J. Taubenberger,et al.  1918 Influenza: the Mother of All Pandemics , 2006, Emerging infectious diseases.

[81]  Keiji Fukuda,et al.  Nonpharmaceutical Interventions for Pandemic Influenza, International Measures , 2006, Emerging infectious diseases.

[82]  E. D. Kilbourne Influenza Pandemics of the 20th Century , 2006, Emerging infectious diseases.

[83]  P. Horby,et al.  Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures , 2006, Emerging infectious diseases.

[84]  T. Uyeki,et al.  Low Frequency of Poultry-to-Human H 5 N 1 Virus Transmission , Southern Cambodia , 2005 , 2006 .

[85]  J. Peiris,et al.  Phylogenetic analysis revealed genetic similarity of the H5N1 avian influenza viruses isolated from HPAI outbreaks in chickens in Maharashtra, India with those isolated from swan in Italy and Iran in 2006 , 2006 .

[86]  Human cases of influenza A(H5N1) infection in eastern Turkey, December 2005-January 2006. , 2006, Releve epidemiologique hebdomadaire.

[87]  T. Kuiken,et al.  Immunopathology and Infectious Diseases Influenza A Virus ( H 5 N 1 ) Infection in Cats Causes Systemic Disease with Potential Novel Routes of Virus Spread within and between Hosts , 2005 .

[88]  J. Peiris,et al.  Use of avian influenza vaccination in Hong Kong. , 2006, Developments in biologicals.

[89]  C. W. Lee,et al.  Avian influenza vaccination in North America: strategies and difficulties. , 2006, Developments in biologicals.

[90]  K. Matsuda,et al.  Pathogenicity of a highly pathogenic avian influenza virus, A/chicken/Yamaguchi/7/04 (H5N1) in different species of birds and mammals , 2006, Archives of Virology.

[91]  C. Macken,et al.  Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses , 2005, Antiviral therapy.

[92]  Yi Guan,et al.  Oseltamivir resistance during treatment of influenza A (H5N1) infection. , 2005, The New England journal of medicine.

[93]  H. Klenk,et al.  The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[94]  F. Lei,et al.  New Genotype of Avian Influenza H5N1 Viruses Isolated from Tree Sparrows in China , 2005, Journal of Virology.

[95]  David E. Swayne,et al.  Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice , 2005, Journal of Virology.

[96]  Y. Guan,et al.  Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells , 2005, Respiratory research.

[97]  Yi Guan,et al.  Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong in 2003 , 2005, Journal of Clinical Microbiology.

[98]  Marius Gilbert,et al.  Highly Pathogenic Avian Influenza H5N1, Thailand, 2004 , 2005, Emerging Infectious Diseases.

[99]  Timothy M. Uyeki,et al.  Family Clustering of Avian Influenza A (H5N1) , 2005, Emerging infectious diseases.

[100]  Calvin M. Johnson,et al.  Transmission of Equine Influenza Virus to Dogs , 2005, Science.

[101]  Hideo Goto,et al.  Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.

[102]  Maria Zambon,et al.  Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. , 2005, The Journal of infectious diseases.

[103]  David E. Swayne,et al.  Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.

[104]  Jeffery K. Taubenberger,et al.  Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.

[105]  Keiji Fukuda,et al.  Evolution of H5N1 Avian Influenza Viruses in Asia , 2005, Emerging infectious diseases.

[106]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.

[107]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[108]  R. Webster,et al.  Molecular Basis of Replication of Duck H5N1 Influenza Viruses in a Mammalian Mouse Model , 2005, Journal of Virology.

[109]  D. Cummings,et al.  Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.

[110]  R. Webster,et al.  Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[111]  Y. Guan,et al.  Are Ducks Contributing to the Endemicity of Highly Pathogenic H5N1 Influenza Virus in Asia? , 2005, Journal of Virology.

[112]  G. Gao,et al.  Highly Pathogenic H5N1 Influenza Virus Infection in Migratory Birds , 2005, Science.

[113]  Y. Guan,et al.  Studies of H5N1 Influenza Virus Infection of Pigs by Using Viruses Isolated in Vietnam and Thailand in 2004 , 2005, Journal of Virology.

[114]  A. H. Law,et al.  p38 Mitogen-Activated Protein Kinase-Dependent Hyperinduction of Tumor Necrosis Factor Alpha Expression in Response to Avian Influenza Virus H5N1 , 2005, Journal of Virology.

[115]  R. Webster,et al.  Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. , 2005, The Journal of infectious diseases.

[116]  A. Nizam,et al.  Containing Pandemic Influenza at the Source , 2005, Science.

[117]  V. Martin,et al.  Origin and evolution of highly pathogenic H5N1 avian influenza in Asia , 2005, Veterinary Record.

[118]  Yoshihiro Kawaoka,et al.  Influenza: lessons from past pandemics, warnings from current incidents , 2005, Nature Reviews Microbiology.

[119]  Y. Guan,et al.  Characterization of a Human H5N1 Influenza A Virus Isolated in 2003 , 2005, Journal of Virology.

[120]  W. Lim,et al.  Influenza A H5N1 Detection , 2005, Emerging infectious diseases.

[121]  Y. Guan,et al.  Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[122]  Y. Guan,et al.  Avian flu: H5N1 virus outbreak in migratory waterfowl , 2005, Nature.

[123]  J. Nicholls,et al.  Influenza A H5N1 Replication Sites in Humans , 2005, Emerging infectious diseases.

[124]  J. Farrar,et al.  Avian Influenza H5N1 and Healthcare Workers , 2005, Emerging infectious diseases.

[125]  B. Lambrecht,et al.  Highly Pathogenic H5N1 Influenza Virus in Smuggled Thai Eagles, Belgium , 2005, Emerging infectious diseases.

[126]  J. Wood,et al.  Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. , 2005, Vaccine.

[127]  R. Bugarini,et al.  Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. , 2005, The Journal of infectious diseases.

[128]  David E. Swayne,et al.  Isolation and Characterization of Avian Influenza Viruses, Including Highly Pathogenic H5N1, from Poultry in Live Bird Markets in Hanoi, Vietnam, in 2001 , 2005, Journal of Virology.

[129]  R. Webster,et al.  Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. , 2005, The Journal of general virology.

[130]  K. Dimock,et al.  Avian influenza and sialic acid receptors: more than meets the eye? , 2005, The Lancet. Infectious diseases.

[131]  Albert D. M. E. Osterhaus,et al.  Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls , 2005, Journal of Virology.

[132]  D. Swayne,et al.  Experimental Study to Determine if Low-Pathogenicity and High-Pathogenicity Avian Influenza Viruses Can Be Present in Chicken Breast and Thigh Meat Following Intranasal Virus Inoculation , 2005, Avian diseases.

[133]  J. Farrar,et al.  Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. , 2005, The New England journal of medicine.

[134]  Yi Guan,et al.  Lethality to Ferrets of H5N1 Influenza Viruses Isolated from Humans and Poultry in 2004 , 2005, Journal of Virology.

[135]  M. Kiso,et al.  Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. , 2005, Virology.

[136]  P. Ward,et al.  Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. , 2005, The Journal of antimicrobial chemotherapy.

[137]  Prasert Auewarakul,et al.  Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. , 2005, The Journal of general virology.

[138]  N. Liem,et al.  Lack of H5N1 Avian Influenza Transmission to Hospital Employees, Hanoi, 2004 , 2005, Emerging infectious diseases.

[139]  S. Dowell,et al.  Human Disease from Influenza A (H5N1), Thailand, 2004 , 2005, Emerging infectious diseases.

[140]  Prasert Auewarakul,et al.  Probable person-to-person transmission of avian influenza A (H5N1). , 2005, The New England journal of medicine.

[141]  Yi Guan,et al.  Detection of Human Influenza A Viruses by Loop-Mediated Isothermal Amplification , 2005, Journal of Clinical Microbiology.

[142]  Vanessa K. Wilson,et al.  HIGHLY PATHOGENIC AVIAN INFLUENZA (H5N1) IN , 2005 .

[143]  R. Webster,et al.  Replication of avian influenza viruses in humans , 2005, Archives of Virology.

[144]  Marius Gilbert,et al.  Highly Pathogenic Avian Influenza H 5 N 1 , Thailand , 2004 , 2005 .

[145]  A. Hedley,et al.  Influenza-associated mortality in Hong Kong. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[146]  R. Webster,et al.  Molecular constraints to interspecies transmission of viral pathogens , 2004, Nature Medicine.

[147]  M. Marra,et al.  Novel Avian Influenza H7N3 Strain Outbreak, British Columbia , 2004, Emerging infectious diseases.

[148]  Yong Poovorawan,et al.  Avian Influenza H5N1 in Tigers and Leopards , 2004, Emerging infectious diseases.

[149]  Martin Hirst,et al.  Human Illness from Avian Influenza H7N3, British Columbia , 2004, Emerging infectious diseases.

[150]  F. Newman,et al.  Serum antibody responses after intradermal vaccination against influenza. , 2004, The New England journal of medicine.

[151]  Y. Guan,et al.  Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002 , 2004, Avian pathology : journal of the W.V.P.A.

[152]  R. Webster,et al.  H5N1 chicken influenza viruses display a high binding affinity for Neu5Acα2-3Galβ1-4(6-HSO3)GlcNAc-containing receptors , 2004 .

[153]  Yoshihiro Kawaoka,et al.  oseltamivir: descriptive study , 2022 .

[154]  Y. Guan,et al.  Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission , 2004, Avian pathology : journal of the W.V.P.A.

[155]  Y Li,et al.  The evolution of H5N1 influenza viruses in ducks in southern China. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[156]  Y. Guan,et al.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.

[157]  A. Charlett,et al.  Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. , 2004, Virus research.

[158]  A. Apisarnthanarak,et al.  Atypical Avian Influenza (H5N1) , 2004, Emerging infectious diseases.

[159]  D. Stallknecht,et al.  Characterization of recent H5 subtype avian influenza viruses from US poultry , 2004, Avian pathology : journal of the W.V.P.A.

[160]  R. Webster,et al.  H5N1 influenza: a protean pandemic threat. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[161]  Y. Guan,et al.  Reemerging H5N1 Influenza Viruses in Hong Kong in 2002 Are Highly Pathogenic to Ducks , 2004, Journal of Virology.

[162]  Y. Guan,et al.  Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines , 2004, The Lancet.

[163]  Constance Schultsz,et al.  Avian influenza A (H5N1) in 10 patients in Vietnam. , 2004, The New England journal of medicine.

[164]  A. Osterhaus,et al.  For Personal Use. Only Reproduce with Permission from the Lancet , 2022 .

[165]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[166]  Marion Koopmans,et al.  Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[167]  M. Marra,et al.  Novel Avian Influenza H7N3 Strain Outbreak , 2004 .

[168]  British Columbia,et al.  Human Illness from Avian Influenza H7N3 , 2004 .

[169]  R. Webster,et al.  H5N1 chicken influenza viruses display a high binding affinity for Neu5Acalpha2-3Galbeta1-4(6-HSO3)GlcNAc-containing receptors. , 2004, Virology.

[170]  C. Bridges,et al.  Transmission of influenza: implications for control in health care settings. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[171]  T. Kuiken,et al.  A Primate Model to Study the Pathogenesis of Influenza A (H5N1) Virus Infection , 2003, Avian diseases.

[172]  Y. Guan,et al.  Avian Influenza in Hong Kong 1997–2002 , 2003, Avian diseases.

[173]  A. Takada,et al.  Neurotropism of the 1997 Hong Kong H5N1 influenza virus in mice. , 2003, Veterinary microbiology.

[174]  R. Krug,et al.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. , 2003, Virology.

[175]  Maria Zambon,et al.  Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population. , 2003, Vaccine.

[176]  Y. Guan,et al.  Neurovirulence in Mice of H5N1 Influenza Virus Genotypes Isolated from Hong Kong Poultry in 2001 , 2003, Journal of Virology.

[177]  H. Klenk,et al.  Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor binding , 2003, Reviews in medical virology.

[178]  F. Mutinelli,et al.  Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza , 2003, Avian pathology : journal of the W.V.P.A.

[179]  J. Crofts Avian influenza in Hong Kong , 2003 .

[180]  R. Morris,et al.  The Impact of a Monthly Rest Day on Avian Tnfluenza Virus Isolation Rates in Retail Live Poultry Markets in Hong Kong N. Y. Kung,AB Y. Guan, N. R. Perkins, L. Bissett,C T. Ellis,C L. Sims,C , 2003 .

[181]  N. Cox,et al.  Pathogenesis of and Immunity to a New Influenza A (H5N1) Virus Isolated from Duck Meat , 2003, Avian diseases.

[182]  Y. Guan,et al.  The Impact of a Monthly Rest Day on Avian Influenza Virus Isolation Rates in Retail Live Poultry Markets in Hong Kong , 2003, Avian diseases.

[183]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[184]  M. Tashiro,et al.  Encephalitis and encephalopathy associated with an influenza epidemic in Japan. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[185]  R. Webster,et al.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses , 2002, Nature Medicine.

[186]  K. Subbarao,et al.  DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. , 2002, Emerging infectious diseases.

[187]  Y. Guan,et al.  Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[188]  T. Tumpey,et al.  Characterization of a Highly Pathogenic H5N1 Avian Influenza A Virus Isolated from Duck Meat , 2002, Journal of Virology.

[189]  R. Webster,et al.  Differences between influenza virus receptors on target cells of duck and chicken , 2002, Archives of Virology.

[190]  C. Olsen The emergence of novel swine influenza viruses in North America. , 2002, Virus research.

[191]  A. García-Sastre Mechanisms of inhibition of the host interferon α/β-mediated antiviral responses by viruses , 2002 .

[192]  Thomas Rowe,et al.  Pathogenesis of Avian Influenza A (H5N1) Viruses in Ferrets , 2002, Journal of Virology.

[193]  H. Klenk,et al.  Functional balance between haemagglutinin and neuraminidase in influenza virus infections , 2002, Reviews in medical virology.

[194]  C. Bridges,et al.  Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. , 2002, The Journal of infectious diseases.

[195]  N. Sugaya Influenza-associated encephalopathy in Japan. , 2002, Seminars in pediatric infectious diseases.

[196]  Y. Guan,et al.  H5N1 influenza viruses isolated from geese in Southeastern China: evidence for genetic reassortment and interspecies transmission to ducks. , 2002, Virology.

[197]  A. García-Sastre Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. , 2002, Microbes and infection.

[198]  Jonathan W. Yewdell,et al.  A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.

[199]  Y. Guan,et al.  Cocirculation of Avian H9N2 and Contemporary “Human” H3N2 Influenza A Viruses in Pigs in Southeastern China: Potential for Genetic Reassortment? , 2001, Journal of Virology.

[200]  R. Webster,et al.  Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses , 2001, Antimicrobial Agents and Chemotherapy.

[201]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[202]  T. Kuiken,et al.  Pathogenesis of Influenza A (H5N1) Virus Infection in a Primate Model , 2001, Journal of Virology.

[203]  F. Hayden,et al.  Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responses , 2001, Journal of medical virology.

[204]  P. Massin,et al.  Residue 627 of PB2 Is a Determinant of Cold Sensitivity in RNA Replication of Avian Influenza Viruses , 2001, Journal of Virology.

[205]  H. Goto,et al.  Generation of a Highly Pathogenic Avian Influenza A Virus from an Avirulent Field Isolate by Passaging in Chickens , 2001, Journal of Virology.

[206]  R. Webster,et al.  Efficacy of Zanamivir against Avian Influenza A Viruses That Possess Genes Encoding H5N1 Internal Proteins and Are Pathogenic in Mammals , 2001, Antimicrobial Agents and Chemotherapy.

[207]  R. Webster,et al.  H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. , 2001, Virology.

[208]  R. Sung,et al.  Pathology of fatal human infection associated with avian influenza A H5N1 virus , 2001, Journal of medical virology.

[209]  W. Blackwelder,et al.  Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. , 2001, Vaccine.

[210]  A. García-Sastre,et al.  Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. , 2001, Virology.

[211]  Yoshihiro Kawaoka,et al.  Pandemic Threat Posed by Avian Influenza A Viruses , 2001, Clinical Microbiology Reviews.

[212]  M. Shaw,et al.  Molecular correlates of influenza A H5N1 virus pathogenesis in mice. , 2001, Journal of virology.

[213]  I. Brown,et al.  H9N2 subtype influenza A viruses in poultry in pakistan are closely related to the H9N2 viruses responsible for human infection in Hong Kong. , 2000, Virology.

[214]  R. Webster,et al.  The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. , 2000, Antiviral research.

[215]  Y. Guan,et al.  H9N2 Influenza Viruses Possessing H5N1-Like Internal Genomes Continue To Circulate in Poultry in Southeastern China , 2000, Journal of Virology.

[216]  K Cameron,et al.  Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[217]  D. Suarez,et al.  Highly Pathogenic Avian Influenza , 2015, Radiology of Infectious Diseases: Volume 1.

[218]  R. Webster,et al.  Characterization of the Influenza A Virus Gene Pool in Avian Species in Southern China: Was H6N1 a Derivative or a Precursor of H5N1? , 2000, Journal of Virology.

[219]  T. Tumpey,et al.  Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans , 2000, Journal of Virology.

[220]  D J Alexander,et al.  A review of avian influenza in different bird species. , 2000, Veterinary microbiology.

[221]  T. Tumpey,et al.  Pathogenesis of and immunity to avian influenza A H5 viruses. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[222]  P. Massin,et al.  Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. , 2000, The Journal of general virology.

[223]  William Ho,et al.  Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. , 2000, The Journal of infectious diseases.

[224]  C. Bridges,et al.  Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. , 1999, The Journal of infectious diseases.

[225]  Walter Fiers,et al.  A universal influenza A vaccine based on the extracellular domain of the M2 protein , 1999, Nature Medicine.

[226]  M. Peiris,et al.  Human infection with influenza H9N2 , 1999, The Lancet.

[227]  N. Cox,et al.  Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. , 1999, Virology.

[228]  Y. Guan,et al.  Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[229]  C. Bridges,et al.  Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. , 1999, The Journal of infectious diseases.

[230]  K. Shortridge Poultry and the influenza H5N1 outbreak in Hong Kong, 1997: abridged chronology and virus isolation. , 1999, Vaccine.

[231]  F. Hayden,et al.  Safety and Efficacy of Intravenous Zanamivir in Preventing Experimental Human Influenza A Virus Infection , 1999, Antimicrobial Agents and Chemotherapy.

[232]  Y. Guo,et al.  [Discovery of men infected by avian influenza A (H9N2) virus]. , 1999, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.

[233]  H. Goto,et al.  Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong , 1999, Journal of Virology.

[234]  Keiji Fukuda,et al.  Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays , 1999, Journal of Clinical Microbiology.

[235]  R. Webster,et al.  DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice , 1999, Journal of Virology.

[236]  R. Webster,et al.  Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. , 1998, The Journal of infectious diseases.

[237]  Yoshihiro Kawaoka,et al.  Molecular Basis for the Generation in Pigs of Influenza A Viruses with Pandemic Potential , 1998, Journal of Virology.

[238]  M. Peiris,et al.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.

[239]  R. Webster,et al.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus , 1998, The Lancet.

[240]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.

[241]  J. Banks,et al.  Characterisation of an avian influenza A virus isolated from a human – is an intermediate host necessary for the emergence of pandemic influenza viruses? , 1998, Archives of Virology.

[242]  Y. Guan,et al.  Copyright � 1996, American Society for Microbiology Emergence of Avian H1N1 Influenza Viruses in Pigs in China , 1996 .

[243]  J. Banks,et al.  Avian influenza virus isolated from a woman with conjunctivitis , 1996, The Lancet.

[244]  W. Fitch,et al.  European swine virus as a possible source for the next influenza pandemic? , 1995, Virology.

[245]  K. Mozdzanowska,et al.  Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice , 1995, Journal of virology.

[246]  R. Webster,et al.  Potential for transmission of avian influenza viruses to pigs. , 1994, The Journal of general virology.

[247]  H. Klenk,et al.  Host cell proteases controlling virus pathogenicity. , 1994, Trends in microbiology.

[248]  B. Murphy,et al.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range , 1993, Journal of virology.

[249]  L. Bossaert,et al.  Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. , 1992, Cytokine.

[250]  Y. Kawaoka,et al.  Location and character of the cellular enzyme that cleaves the hemagglutinin of a virulent avian influenza virus. , 1992, Virology.

[251]  N. Katunuma,et al.  Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. , 1992, The Journal of biological chemistry.

[252]  Shortridge Kf Pandemic influenza: a zoonosis? , 1992, Seminars in respiratory infections.

[253]  L. Bossaert,et al.  Interleukin-8 (il-8) in the bronchoalveolar lavage (bal) fluid from patients with the adult respiratory-distress syndrome (ards) , 1992 .

[254]  W. J. Bean,et al.  Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts , 1992, Journal of virology.

[255]  K. Shortridge Pandemic influenza: a zoonosis? , 1992, Seminars in respiratory infections.

[256]  J. Paulson,et al.  Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. , 1990, Acta histochemica. Supplementband.

[257]  R. Webster,et al.  Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics , 1989, Journal of virology.

[258]  B. Murphy,et al.  The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys , 1987, Journal of virology.

[259]  R. Webster,et al.  Distribution of hemagglutinin and neuraminidase on influenza virions as revealed by immunoelectron microscopy. , 1986, Virology.

[260]  C. Naeve,et al.  Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? , 1984, Virology.

[261]  C. Naeve,et al.  Altered tissue tropism of human-avian reassortant influenza viruses. , 1983, Virology.

[262]  J. Paulson,et al.  Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. , 1983, Virology.

[263]  P. Palese,et al.  Genetics of influenza viruses , 1983 .

[264]  R. Webster,et al.  Failure to Detect Hemagglutination-Inhibiting Antibodies with Intact Avian Influenza Virions , 1982, Infection and immunity.

[265]  K. Shortridge,et al.  AN INFLUENZA EPICENTRE? , 1982, The Lancet.

[266]  R. Webster,et al.  Virulence of Avian Influenza A Viruses for Squirrel Monkeys , 1982, Infection and immunity.

[267]  G. Air,et al.  Variation in the membrane-insertion and "stalk" sequences in eight subtypes of influenza type A virus neuraminidase. , 1982, Biochemistry.

[268]  R. Webster,et al.  Conjunctivitis in human beings caused by influenza A virus of seals. , 1981, The New England journal of medicine.

[269]  R. Jennings,et al.  Responses of volunteers to inactivated influenza virus vaccines , 1981, Journal of Hygiene.

[270]  C. Scholtissek,et al.  On the origin of the human influenza virus subtypes H2N2 and H3N2. , 1978, Virology.

[271]  H. Dowling Epidemic and peace, 1918 , 1976, Medical History.

[272]  R. Webster,et al.  Persistence of Hong Kong influenza virus variants in pigs. , 1977, Science.

[273]  A. J. Turner,et al.  A case report of fowl plague keratoconjunctivitis. , 1977, The British journal of ophthalmology.

[274]  R. Webster,et al.  Antibodies to human influenzavirus neuraminidase (the A-Asian-57 H2N2 strain) in sera from Australian pelagic birds. , 1972, Bulletin of the World Health Organization.

[275]  R. Webster,et al.  Fowl plague virus from man. , 1970, The Journal of infectious diseases.

[276]  R. Chanock,et al.  Mutants of influenza virus. , 1969, British medical journal.

[277]  H. Tubiash,et al.  Comparative study of fowl plague virus and a virus isolated from man. , 1967, Public health reports.

[278]  F. Burnet A genetic approach to variation in influenza viruses; variation in the strain NWS on allantoic passage. , 1951, Journal of general microbiology.

[279]  F. Burnet,et al.  A genetic approach to variation in influenza viruses; recombination of characters in influenza virus strains used in mixed infections. , 1951, Journal of general microbiology.

[280]  J. Taubenberger,et al.  Influenza : the Mother of All Pandemics , 2022 .